Company:  PACIRA BIOSCIENCES, INC. (PCRX)
Form Type:  SC 13G/A
Filing Date:  10/9/2019 
CIK:  0001396814 
Address:  5 SYLVAN WAY
SUITE 300
 
City, State, Zip:  PARSIPPANY, New Jersey 07054 
Telephone:  973-254-3560 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$55.33  
Change: 
-0.25 (-0.45%)  
Trade Time: 
Jul 14  
Market Cap: 
$2.33B
Trade PCRX now with 

© 2020  
Description of Business
Pacira BioSciences, Inc., a Delaware corporation, changed its name from Pacira Pharmaceuticals, Inc. upon completing its acquisition of MyoScience, a privately-held medical technology company, in April 2019 (referred to herein as the "MyoScience Acquisition") in order to better reflect a broadening portfolio of innovative non-opioid pain management and regenerative health solutions. Pacira BioSciences, Inc. is the holding company for our California operating subsidiary named Pacira Pharmaceuticals, Inc., or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc. (now a subsidiary of Vectura Group plc), or Skyepharma (referred to herein as the "Skyepharma Acquisition"). Pacira California retained the name Pacira Pharmaceuticals, Inc. upon the completion of the MyoScience Acquisition. Unless the context requires otherwise, references to "Pacira," "we," the "Company," "us" and "our" in this Annual Report refers to Pacira BioSciences, Inc.
Register and access this filing in:     
  FORM SC 13G/A